Literature DB >> 25274608

Prediction of drug clearance in children: an evaluation of the predictive performance of several models.

Iftekhar Mahmood1, Carl-Michael Staschen, Kosalaram Goteti.   

Abstract

The objective of this study is to evaluate the predictive performance of several models to predict drug clearance in children ≤5 years of age. Six models (allometric model (data-dependent exponent), fixed exponent of 0.75 model, maturation model, body weight-dependent model, segmented allometric model, and age-dependent exponent model) were evaluated in this study. From the literature, the clearance values for six drugs from neonates to adults were obtained. External data were used to evaluate the predictive performance of these models in children ≤5 years of age. With the exception of a fixed exponent of 0.75, the mean predicted clearance in most of the age groups was within ≤50% prediction error. Individual clearance prediction was erratic by all models and cannot be used reliably to predict individual clearance. Maturation, body weight-dependent, and segmented allometric models to predict clearances of drugs in children ≤5 years of age are of limited practical value during drug development due to the lack of availability of data. Age-dependent exponent model can be used for the selection of first-in-children dose during drug development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274608      PMCID: PMC4389735          DOI: 10.1208/s12248-014-9667-7

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  40 in total

Review 1.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Basal metabolic rates in mammals: taxonomic differences in the allometry of BMR and body mass.

Authors:  V Hayssen; R C Lacy
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1985

3.  A distinction must be made between the ontogeny and the phylogeny of metabolism in order to understand the mass exponent of energy metabolism.

Authors:  W Wieser
Journal:  Respir Physiol       Date:  1984-01

Review 4.  Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm.

Authors:  H Boxenbaum
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

5.  Human cytochrome P450 maximal activities in pediatric versus adult liver.

Authors:  J G Blanco; P L Harrison; W E Evans; M V Relling
Journal:  Drug Metab Dispos       Date:  2000-04       Impact factor: 3.922

6.  Protein binding predictions in infants.

Authors:  Patrick J McNamara; Jane Alcorn
Journal:  AAPS PharmSci       Date:  2002

Review 7.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants.

Authors:  W L Hayton; J Kneer; R de Groot; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.

Authors:  Chenguang Wang; Karel Allegaert; Mariska Y M Peeters; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 10.  Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Authors:  Gregory L Kearns; Susan M Abdel-Rahman; Sarah W Alander; Douglas L Blowey; J Steven Leeder; Ralph E Kauffman
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

View more
  11 in total

1.  Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.

Authors:  Iftekhar Mahmood; Million A Tegenge
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

2.  Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.

Authors:  Iftekhar Mahmood
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

3.  Ontogeny of Scaling Factors for Pediatric Physiology-Based Pharmacokinetic Modeling and Simulation: Microsomal Protein Per Gram of Liver.

Authors:  J Steven Leeder; Jean C Dinh; Andrea Gaedigk; Vincent S Staggs; Bhagwat Prasad; Robin E Pearce
Journal:  Drug Metab Dispos       Date:  2021-10-22       Impact factor: 3.922

4.  A General Biphasic Bodyweight Model for Scaling Basal Metabolic Rate, Glomerular Filtration Rate, and Drug Clearance from Birth to Adulthood.

Authors:  Teh-Min Hu
Journal:  AAPS J       Date:  2022-05-10       Impact factor: 3.603

5.  Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical Models.

Authors:  Iftekhar Mahmood; Carl-Michael Staschen
Journal:  AAPS J       Date:  2016-01-22       Impact factor: 4.009

Review 6.  The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.

Authors:  Justine Badée; Stephen Fowler; Saskia N de Wildt; Abby C Collier; Stephan Schmidt; Neil Parrott
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

7.  Allometric Considerations on Proteins Administered Intravitreally to Children.

Authors:  Thomas Eissing
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08-22

8.  Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method.

Authors:  E A M Calvier; E H J Krekels; T N Johnson; A Rostami-Hodjegan; D Tibboel; Catherijne A J Knibbe
Journal:  AAPS J       Date:  2019-03-08       Impact factor: 4.009

9.  A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically-Based Pharmacokinetics for Pediatric Dosing Using Clearance as a Surrogate.

Authors:  Qier Wu; Sheila Annie Peters
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-02-26

10.  Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?

Authors:  Elisa A M Calvier; Elke H J Krekels; Pyry A J Välitalo; Amin Rostami-Hodjegan; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.